Peer-reviewed publications as of June 1, 2024: 100 original articles, letters and reviews; h-index: 20; i10-index: 38; total citations: 3,356 (Google Scholar statistics).

Asterisks (*) indicate equal author contributions / shared authorships.

2022

Bourgonje AR, van den Berg EH, Kieneker LM, Nilsen T, Hidden C, Sundrehagen E, Gansevoort RT, Bakker SJL, Blokzijl H, Dullaart RPF, van Goor H, Abdulle AE. Plasma Calprotectin levels Associate with Suspected Metabolic-Associated Fatty Liver Disease and All-Cause Mortality in the General Population. Int J Mol Sci 2022;23(24):15708. doi: 10.3390/ijms232415708.

Otten AT^*, Bourgonje AR^*, Visschedijk MC. Working towards a comprehensive appraisal of vaccine-induced immunity against SARS-CoV-2 in IBD. Lancet Gastroenterol Hepatol 2023;8(2):99-100. doi: 10.1016/S2468-1253(22)00404-6.

Bourgonje AR. Microbial Riboflavin Biosynthesis Associates With Response to Dietary Fiber Consumption: Time to Personalize Adjunct Therapy in Patients With Inflammatory Bowel Disease? Gastroenterology 2023;165(2):515-516. doi: 10.1053/j.gastro.2022.10.016.

Spraakman NA, Coester AM, Bourgonje AR, Nieuwenhuijs VB, Sanders JSF, Leuvenink HGD, van Goor H, Nieuwenhuijs-Moeke GJ. Systemic and Renal Dynamics of Free Sulfhydryl Groups during Living Donor Kidney Transplantation. Int J Mol Sci 2022;23(17):9789. doi: 10.3390/ijms23179789.

Bourgonje AR, Wichers SJ, Hu S, van Dullemen HM, Visschedijk MC, Faber KN, Festen EAM, Dijkstra G, Samsom JN, Weersma RK, Spekhorst LM. Proteomic analyses do not reveal subclinical inflammation in fatigued patients with clinically quiescent inflammatory bowel disease. Sci Rep 2022;12(1):14581. doi: 10.1038/s41598-022-17504-5.

Bourgonje AR, Otten AT, Sadaghian Sadabad M, von Martels JZH, Bulthuis MLC, Faber KN, van Goor H, Dijkstra G, Harmsen HJM. The effect of riboflavin supplementation on the systemic redox status in healthy volunteers: A post-hoc analysis of the RIBOGUT trial. Free Radic Biol Med 2022;190:169-178. doi: 10.1016/j.freeradbiomed.2022.08.008.

Bourgonje AR. Evaluating Discriminative Accuracy of Biomarkers in Relation to Binary Study Outcomes: First Validate, Then Celebrate? J Crohns Colitis 2023;17(1):146. doi: 10.1093/ecco-jcc/jjac117.

van Eijk LE, Offringa AK, Bernal ME, Bourgonje AR, van Goor H, Hillebrands JL. The Disease-Modifying Role of Taurine and Its Therapeutic Potential in Coronavirus Disease 2019 (COVID-19). Adv Exp Biol Med 2022;1370:3-21. doi: 10.1007/978-3-030-93337-1_1.

Alexdottir M^*, Bourgonje AR^*, Karsdal MA, Bay-Jensen AC, Pehrsson M, Loveikyte R, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, Faber KN, Dijkstra G, Mortensen JH. Serological Biomarkers of Extracellular Matrix Turnover and Neutrophil Activity Are Associated with Long-Term Use of Vedolizumab in Patients with Crohn’s Disease. Int J Mol Sci 2022;23(15):8137. doi: 10.3390/ijms23158137.

Gabriëls RY^*, Bourgonje AR^*,von Martels JZH, Trentadue G, Blokzijl T, van Dullemen HM, Festen EAM, Visschedijk MC, Weersma RK, Galinsky K, Juarez J, Kats-Ugurlu G, Faber KN, Dijkstra G. Mucosal Eosinophil Abundance in Non-Inflamed Colonic Tissue Is Associated with Response to Vedolizumab Induction Therapy in Inflammatory Bowel Disease. J Clin Med 2022;11(14):4141. doi: 10.3390/jcm11144141.

Alexdottir M^*, Bourgonje AR^*, Karsdal MA, Bay-Jensen AC, Loveikyte R, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, Faber KN, Dijkstra G, Mortensen JH. Serological Biomarkers of Intestinal Collagen Turnover Identify Early Response to Infliximab Therapy in Patients With Crohn’s Disease. Front Med (Lausanne) 2022;9:933872. doi: 10.3389/fmed.2022.933872.

Otten AT^*, Bourgonje AR^*, Horinga PP, van der Meulen HH, van Leer-Buter C, Dijkstra G, Visschedijk MC. Use of Tumor Necrosis Factor-α Antagonists Is Associated With Attenuated IgG Antibody Response Against SARS-CoV-2 in Vaccinated Patients With Inflammatory Bowel Disease. Front Immunol 2022;13:920333. doi: 10.3389/fimmu.2022.920333.

Visser K, van der Horn, Bourgonje AR, Jacobs B, Vos PE, Bulthuis MLC, van Goor H, van der Naalt J. Acute serum free thiols: a potentially modifiable biomarker of oxidative stress following traumatic brain injury. J Neurol 2022;269(11):5883-5892. doi: 10.1007/s00415-022-11240-6.

Bourgonje AR^*, Bolte LA^*, Vranckx LLC, Spekhorst LM, Gacesa R, Hu S, van Dullemen HM, Visschedijk MC, Festen EAM, Samsom JN, dijkstra G, Weersma RK, Campmans-Kuijpers MJE. Long-Term Dietary Patterns Are Reflected in the Plasma Inflammatory Proteome of Patients with Inflammatory Bowel Disease. Nutrients 2022;14(12):2522. doi: 10.3390/nu14122522.

Bourgonje AR, Bourgonje MF, Post A, la Bastide-van Gemert S, Kieneker LM, Bulthuis MLC, Gordijn SJ, Gansevoort RT, Bakker SJL, Mulder DJ, Pasch A, van Goor H, Abdulle AE. Systemic oxidative stress associates with new-onset hypertension in the general population. Free Radic Biol Med 2022;187:123-131. doi: 10.1016/j.freeradbiomed.2022.05.020.

Bergsma A, Li HT, van Eliveld J, Bulthuis MLC, Hoek A, van Goor H, Bourgonje AR, Cantineau AEP. Local and Systemic Oxidative Stress Biomarkers for Male Infertility: the ORION Study. Antioxidants 2022;11(6):1045. doi: 10.3390/antiox11061045.

Fagundes RR^*, Bourgonje AR^*, Hu S, Barbieri R, Jansen BH, Weersma RK, Taylor CT, Faber KN, Dijkstra G. HIF1α-Dependent Induction of TFRC by a Combination of Intestinal Inflammation and Systemic Iron Deficiency in Inflammatory Bowel Disease. Front Physiol 2022;13:889091. doi: 10.3389/fphys.2022.889091.

Bourgonje AR^*, Alexdottir M^*, Otten AT, Loveikyte R, Bay-Jensen AC, van Dullemen HM, Visschedijk MC, Festen EAM, Weersma RK, Karsdal MA, Faber KN, Mortensen JH, Dijkstra G. Serological biomarkers of type I, III and IV collagen turnover are associated with the presence and future progression of stricturing and penetrating Crohn’s disease. Aliment Pharmacol Ther 2022;56(4):675-693. doi: 10.1111/apt.17063.

Bourgonje AR, Vogl T, Segal E, Weersma RK. Antibody signatures in inflammatory bowel disease: current developments and future applications. Trends Mol Med 2022;28(8):693-705. doi: 10.1016/j.molmed.2022.05.004.

Bourgonje AR, Roo-Brand G, Lisotto P, Sadaghian Sadabad M, Reitsema RD, de Goffau MC, Faber KN, Dijkstra G, Harmsen HJM. Patients With Inflammatory Bowel Disease Show IgG Immune Responses Towards Specific Intestinal Bacterial Genera. Front Immunol 2022;13:842911. doi: 10.3389/fimmu.2022.842911.

van der Slikke EC, Boekhoud L, Bourgonje AR, Olgers TJ, ter Maaten JC, Henning RH, van Goor H, Bouma HR. Plasma Free Thiol Levels during Early Sepsis Predict Future Renal Function Decline. Antioxidants 2022;11(5):800. doi: 10.3390/antiox1105800.

Leimkühler M, Bourgonje AR, van Goor H, Campmans-Kuijpers MJE, de Bock GH, van Leeuwen BL. ASO Visual Abstract: Oxidative Stress Predicts Post-surgery Complications in Gastrointestinal Cancer Patients. Ann Surg Oncol 2022;29(7):4550-1. doi: 10.1245/s10434-022-11685-z.

Savelkoul EHJ, Maas MHJ, Bourgonje AR, Crouwel F, Biemans VBC, den Broeder N, Russel MGVM, Römkens TEH, de Boer NKH, Dijkstra G, Hoentjen F. Favourable Tolerability and Drug Survival of Tioguanine Versus Methotrexate After Failure of Conventional Thiopurines in Crohn’s Disease. J Crohns Colitis 2022;16(9):1372-1379. doi: 10.1093/ecco-jcc/jjac044.

Leimkühler M, Bourgonje AR, van Goor H, Campmans-Kuijpers MJE, de Bock GH, van Leeuwen BL. ASO Author Reflections: Oxidative Stress as a Predictor of Short-Term Outcome After Oncological Surgery for Gastrointestinal Cancer. Ann Surg Oncol 2022;29(7):4548-9. doi: 10.1245/s10434-022-11453-z.

Leimkühler M, Bourgonje AR, van Goor H, Campmans-Kuijpers MJE, de Bock GH, van Leeuwen BL. Oxidative Stress Predicts Post-Surgery Complications in Gastrointestinal Cancer Patients. Ann Surg Oncol 2022;29(7):4540-4547. doi: 10.1245/s10434-022-11412-8.

Al Hasan A, Reimann F, Veeger NJGM, Bergstra SA, Zhang D, Bourgonje AR, Hendriks L, Riofrio LZ, Wink F, Schilder A, Huizinga TWJ, Bos R. Optical imaging compared to clinical examination in 484 rheumatoid arthritis patients: the Leeuwarden Handscan Registry. Rheumatol Int 2022;42(11):2019-2026. doi: 10.1007/s00296-021-05060-6.